Literature DB >> 2968520

Regulatory properties of LFA-1 alpha and beta chains in human T-lymphocyte activation.

C van Noesel1, F Miedema, M Brouwer, M A de Rie, L A Aarden, R A van Lier.   

Abstract

Lymphocyte function-associated antigen-1 (LFA-1) is a heterodimer composed of an alpha and beta chain that is expressed on the surface of most leukocytes and is an essential molecule for adhesion reactions between cells participating in the immune response. A putative ligand for LFA-1 is the intercellular adhesion molecule ICAM-1 (refs 3-5). Leukocyte adhesion abnormality is found in patients with LFA-1 deficiency. It is not clear whether binding of ligand to the LFA-1 molecule merely spatially orientates cells towards each other or can also induce signals that regulate cell activation and differentiation. We have recently developed a T-cell proliferation assay which uses immobilized anti-CD3 monoclonal antibodies as stimulant and is independent of LFA-1-mediated cellular adhesion. As there is no interference by anti-LFA-1 monoclonal antibodies with the adhesion-dependent activation steps, this T-cell activation system allows us to investigate whether transmembrane signals are induced by binding of ligand to LFA-1 on T cells. Our data indicate that binding of ligand to LFA-1 results in the transduction of regulatory signal across the plasma membrane, rather like other molecules (CD2, CD4, CD8) (refs 8-11) with signal-modifying properties involved in the adhesion of T cells to target/stimulator cells. Indeed, adhesion molecules might generally be important in signal transduction, even in cells not belonging to the immune system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2968520     DOI: 10.1038/333850a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  51 in total

Review 1.  The role of adhesion molecules in endothelial cell accessory function.

Authors:  J R Westphal; R M de Waal
Journal:  Mol Biol Rep       Date:  1992-11       Impact factor: 2.316

2.  Growth stimulation of tumor-specific cytotoxic T lymphocytes on concanavalin a-immobilized carrier beads.

Authors:  S Q Liu; L S Liu; T Ohno
Journal:  Cytotechnology       Date:  1998-01       Impact factor: 2.058

Review 3.  Regulation of IgE synthesis in humans.

Authors:  D Vercelli; R S Geha
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

4.  Leukocyte adhesion deficiency type 1 (LAD-1)/variant. A novel immunodeficiency syndrome characterized by dysfunctional beta2 integrins.

Authors:  T W Kuijpers; R A Van Lier; D Hamann; M de Boer; L Y Thung; R S Weening; A J Verhoeven; D Roos
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

5.  B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2.

Authors:  C D Gimmi; G J Freeman; J G Gribben; K Sugita; A S Freedman; C Morimoto; L M Nadler
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

6.  Cystatin C deficiency promotes inflammation in angiotensin II-induced abdominal aortic aneurisms in atherosclerotic mice.

Authors:  Stephanie Schulte; Jiusong Sun; Peter Libby; Lindsey Macfarlane; Chongxiu Sun; Marco Lopez-Ilasaca; Guo-Ping Shi; Galina K Sukhova
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

7.  Anti-leucocyte common (CD45) antibodies inhibit dendritic cell stimulation of CD4 and CD8 T-lymphocyte proliferation.

Authors:  T C Prickett; D N Hart
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

8.  Compensation for decreased expression of B7 molecules on Leishmania infantum-infected canine macrophages results in restoration of parasite-specific T-cell proliferation and gamma interferon production.

Authors:  E Pinelli; V P Rutten; M Bruysters; P F Moore; E J Ruitenberg
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

9.  The mitogenic activity of human T-cell leukemia virus type I is T-cell associated and requires the CD2/LFA-3 activation pathway.

Authors:  J T Kimata; T J Palker; L Ratner
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

10.  Anti-leucocyte function-associated antigen-1 antibodies inhibit T-cell activation following low-avidity and adhesion-independent interactions.

Authors:  G Gorochov; G Gross; T Waks; Z Eshhar
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.